Your browser doesn't support javascript.
loading
Prolonged persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals.
Saurabh, S; Kumar, R; Gupta, M K; Bhardwaj, P; Nag, V L; Garg, M K; Misra, S.
Afiliação
  • Saurabh S; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur 342005, India.
  • Kumar R; Engineering Science Laboratory - Central Scientific Instruments Organization (CSIO), Council for Scientific and Industrial Research (CSIR), Chandigarh 160030, India.
  • Gupta MK; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur 342005, India.
  • Bhardwaj P; Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences (AIIMS), Jodhpur 342005, India.
  • Nag VL; Department of Microbiology.
  • Garg MK; Department of General Medicine.
  • Misra S; Director, All India Institute of Medical Sciences (AIIMS), Jodhpur 342005, India.
QJM ; 113(8): 556-560, 2020 Aug 01.
Article em En | MEDLINE | ID: mdl-32609360
ABSTRACT

BACKGROUND:

Duration of persistence of SARS-CoV-2 in the upper respiratory tract of infected individuals has important clinical and epidemiological implications.

AIM:

We aimed to establish the duration and risk factors for persistence of SARS-CoV-2 in the upper respiratory tract of asymptomatic infected individuals.

METHODS:

Data of repeat rRT-PCR (real-time reverse transcription-polymerase chain reaction) test done for SARS-CoV-2 infected individuals at our institute at Jodhpur, India were analysed from 19 March to 21 May 2020. Duration of virus persistence was estimated with parametric regression models based on weibull, log-normal, log-logistic, gamma and generalized gamma distributions. Factors associated with prolonged viral persistence were analysed with the best-fitting model.

RESULTS:

Fifty-one SARS-CoV-2 infected individuals with repeat rRT-PCR test were identified with 44 asymptomatics. The asymptomatic individuals had median virus persistence duration of 8.87 days (95% CI 7.65-10.27) and 95 percentile duration of 20.70 days (95% CI 16.08-28.20). The overall median virus persistence including both symptomatic and asymptomatic individuals was found to be 9.18 days (95% CI 8.04-10.48). Around one-fourth asymptomatics (10/44) demonstrated SARS-CoV-2 persistence beyond 2 weeks. Age <60 years and local transmission were found to be significantly associated with longer virus persistence among asymptomatic individuals on univariate regression but not in multivariate analysis.

CONCLUSION:

Recommended home isolation duration for SARS-CoV-2 infected individuals in India should be extended from 17 days to at least 3 weeks. Prolonged persistence of SARS-CoV-2 in a considerable proportion of asymptomatic individuals merits attention with regard to ensuring universal infection prevention precautions irrespective of symptomatic status.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orofaringe / Pneumonia Viral / Nasofaringe / Infecções por Coronavirus / Infecções Assintomáticas / Betacoronavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: QJM Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Orofaringe / Pneumonia Viral / Nasofaringe / Infecções por Coronavirus / Infecções Assintomáticas / Betacoronavirus Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: QJM Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Índia